In this study we demonstrate that the regulator of FGFR4 mRNA expression are not somatic variants or copy number alterations but instead appears to be DNA hypomethylation of regions in the gene’s promoter, acting as an apparent switch for FGFR4 expression in breast cancer. Here, FGFR4 is linked to breast carcinoma.